Search research articles
Contact Us
Filters
Showing results (81-90 of 142) with videos related to
Page
of 15
Sort By:
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
March 22, 2021
On-Chip Biogenesis of Circulating NK Cell-Derived Exosomes in Non-Small Cell Lung Cancer Exhibits Antitumoral Activity
Yoon-Tae Kang, Zeqi Niu, Thomas Hadlock, et al.
Diabetes Care
|
March 3, 2022
Immune Checkpoint Inhibitors and Risk of Type 1 Diabetes
Xuan Chen, Alison H Affinati, Yungchun Lee, et al.
Cancer Chemotherapy and Pharmacology
|
February 5, 2008
In vitro and in vivo evaluation of combined calcitriol and cisplatin in dogs with spontaneously occurring tumors
Kenneth M Rassnick, Josephia R Muindi, Candace S Johnson, et al.
Free Radical Biology & Medicine
|
December 27, 2006
High superoxide dismutase and low glutathione peroxidase activities in red blood cells predict susceptibility of lung cancer patients to radiation pneumonitis
Eun-Mi Park, Nithya Ramnath, Gary Y Yang, et al.
Cell Reports
|
January 23, 2024
Circulating tumor cells reveal early predictors of disease progression in patients with stage III NSCLC undergoing chemoradiation and immunotherapy
Emma Purcell, Zeqi Niu, Sarah Owen, et al.
The Journal of Biological Chemistry
|
March 14, 2020
The cytochrome P450 enzyme CYP24A1 increases proliferation of mutant KRAS-dependent lung adenocarcinoma independent of its catalytic activity
Wei Huang, Paramita Ray, Wenbin Ji, et al.
Scientific Reports
|
January 3, 2024
Class II HLA-DRB4 is a predictive biomarker for survival following immunotherapy in metastatic non-small cell lung cancer
Cindy Y Jiang, Lili Zhao, Michael D Green, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 4, 2007
Induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for regionally advanced unresectable stage III Non-small-cell lung cancer: Cancer and Leukemia Group B
Everett E Vokes, James E Herndon, Michael J Kelley, et al.
Scientific Reports
|
January 26, 2019
PD-L1 Expression in Circulating Tumor Cells Increases during Radio(chemo)therapy and Indicates Poor Prognosis in Non-small Cell Lung Cancer
Yang Wang, Tae Hyun Kim, Shamileh Fouladdel, et al.
Journal for Immunotherapy of Cancer
|
May 14, 2026
Morning versus afternoon administration of immune checkpoint inhibitors in metastatic non-small-cell lung cancer
Rachel T Gonzalez, Reena Datta, Sadiq Rehmani, et al.
Page
of 15
Search research articles
Search
Showing results (81-90 of 142) with videos related to
Sort By:
Page
of 15
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
March 22, 2021
On-Chip Biogenesis of Circulating NK Cell-Derived Exosomes in Non-Small Cell Lung Cancer Exhibits Antitumoral Activity
Yoon-Tae Kang, Zeqi Niu, Thomas Hadlock, et al.
Diabetes Care
|
March 3, 2022
Immune Checkpoint Inhibitors and Risk of Type 1 Diabetes
Xuan Chen, Alison H Affinati, Yungchun Lee, et al.
Cancer Chemotherapy and Pharmacology
|
February 5, 2008
In vitro and in vivo evaluation of combined calcitriol and cisplatin in dogs with spontaneously occurring tumors
Kenneth M Rassnick, Josephia R Muindi, Candace S Johnson, et al.
Free Radical Biology & Medicine
|
December 27, 2006
High superoxide dismutase and low glutathione peroxidase activities in red blood cells predict susceptibility of lung cancer patients to radiation pneumonitis
Eun-Mi Park, Nithya Ramnath, Gary Y Yang, et al.
Cell Reports
|
January 23, 2024
Circulating tumor cells reveal early predictors of disease progression in patients with stage III NSCLC undergoing chemoradiation and immunotherapy
Emma Purcell, Zeqi Niu, Sarah Owen, et al.
The Journal of Biological Chemistry
|
March 14, 2020
The cytochrome P450 enzyme CYP24A1 increases proliferation of mutant KRAS-dependent lung adenocarcinoma independent of its catalytic activity
Wei Huang, Paramita Ray, Wenbin Ji, et al.
Scientific Reports
|
January 3, 2024
Class II HLA-DRB4 is a predictive biomarker for survival following immunotherapy in metastatic non-small cell lung cancer
Cindy Y Jiang, Lili Zhao, Michael D Green, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 4, 2007
Induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for regionally advanced unresectable stage III Non-small-cell lung cancer: Cancer and Leukemia Group B
Everett E Vokes, James E Herndon, Michael J Kelley, et al.
Scientific Reports
|
January 26, 2019
PD-L1 Expression in Circulating Tumor Cells Increases during Radio(chemo)therapy and Indicates Poor Prognosis in Non-small Cell Lung Cancer
Yang Wang, Tae Hyun Kim, Shamileh Fouladdel, et al.
Journal for Immunotherapy of Cancer
|
May 14, 2026
Morning versus afternoon administration of immune checkpoint inhibitors in metastatic non-small-cell lung cancer
Rachel T Gonzalez, Reena Datta, Sadiq Rehmani, et al.
Page
of 15